Paniskaki, Krystallenia, Goretzki, Sarah, Anft, Moritz et al. · Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2023 · DOI
This study looked at children who had COVID-19 and developed long-lasting symptoms like breathing problems, fatigue, and brain fog—a condition called pediatric long COVID. Researchers found that these children had more immune cells fighting the virus that were less effective than usual, and these cells released inflammatory chemicals that may have been causing their symptoms. The findings suggest that ongoing immune system activation after COVID-19 might explain why some children develop persistent health problems similar to ME/CFS.
This study provides mechanistic insights into how persistent immune activation following viral infection may contribute to ME/CFS-like symptoms in children, bridging post-COVID sequelae research with ME/CFS pathophysiology. Understanding these immune signatures could eventually inform targeted therapeutic approaches for both pediatric long COVID and ME/CFS patients who may share similar underlying mechanisms.
This study does not prove that low-avidity T cells directly cause PASC symptoms—it shows correlation, not causation. The cross-sectional design captures only a single timepoint and cannot establish whether immune abnormalities precede symptom onset or result from ongoing symptoms. Results cannot be generalized beyond the small pediatric cohort studied.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.